Cormorant Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Cormorant Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,425,000	Closed	-$35.3M	–	84
2022 Q2	$35.3M	Buy	1,425,000 +560,000	+65%	+$12.3M	2.67%	8
2022 Q1	$21.7M	Buy	865,000 +465,000	+116%	+$13.1M	1.67%	18
2021 Q4	$14.6M	Buy	+400,000	New	+$14M	0.87%	34
2021 Q2	–	Sell	-850,000	Closed	-$43.6M	–	131
2021 Q1	$43.6M	Sell	850,000 -350,000	-29%	-$21.1M	0.97%	25
2020 Q4	$74.3M	Sell	1,200,000 -200,000	-14%	-$11.5M	1.77%	19
2020 Q3	$76.7M	Sell	1,400,000 -300,000	-18%	-$16.2M	2.95%	6
2020 Q2	$97.8M	Sell	1,700,000 -325,000	-16%	-$17.7M	3.73%	4
2020 Q1	$81.4M	Sell	2,025,000 -875,000	-30%	-$37.2M	3.78%	5
2019 Q4	$115M	Buy	2,900,000 +1,080,000	+59%	+$19M	4.58%	4
2019 Q3	$12.3M	Sell	1,820,000 -545,280	-23%	-$4.09M	0.75%	40
2019 Q2	$22M	Sell	2,365,280 -160,620	-6%	-$1.86M	1.26%	27
2019 Q1	$35.1M	Buy	+2,525,900	New	+$28.9M	2.37%	14

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Cormorant Asset Management's CCXI Position: Q3 2022 in Review

Cormorant Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 1,425,000 shares — an estimated $35.3M sold.

Cormorant Asset Management first reported a position in CCXI in Q1 2019 and held it in 12 quarters. The position peaked at $115M in Q4 2019. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

Cormorant Asset Management reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
Cormorant Asset Management sold 1,425,000 ChemoCentryx, Inc. shares in Q3 2022, an estimated $35.3M.
Cormorant Asset Management first reported a position in ChemoCentryx, Inc. in Q1 2019 and held it in 12 quarters.
Cormorant Asset Management's ChemoCentryx, Inc. position peaked at $115M in Q4 2019.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Cormorant Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.